top of page
News
Chat
Analysis
Education
About
Pricing
BPIQ API
BPIQ Blog
Jul 18, 2021
6 min read
What to do Now with FGEN After FDA Meltdown
Summary: FGEN stock was crushed last week on strong votes against Roxadustat in both DD and NDD by FDA AdComm Big-Mover event In battle...
Jul 11, 2021
8 min read
Is FGEN a Buy Going Into Roxa AdComm?
Summary: FGEN stock has been on a long-term downward cycle since peaking in 2018, mainly because of complications/miscommunications...
May 29, 2019
2 min read
CARA Reports Success in Kidney Disease Itching
Congrats to CARA on a well-executed and positive Phase 3 trial of KORSUVA injection for reduction of pruritis (severe itching) in...
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page